ruxolitinib,pelabresib
constellation Pharmaceuticals,novartis,incyte,morphosys
['#mpn', 'ruxolitinib', 'beyond,trial', 'mpnsm', 'nct04603495', 'rux,(-crux),(-trux)', 'manifest-2', 'rux,(-crux),(-trux),(-deruxtecan)', 'emergent ']
#ash22| john mascarenhas discusses response durability of pelabresib in combination with rux for pts with mf. 83% of pts achieved a tss50 at any point during the study while 40% achieved 1 bm fibrosis grade improvement at any time #mpn #mpnsm #medicalcongress 
Lifting levels of knowledge in myeloproliferative neoplasms (MPN). A global online platform providing latest treatment options and medical information #mpnsm